Physician profile
Megan Jo Petty
NPI 1255332433
$1,663.94
in general payments reported to CMS, 2019-2025
10 companies · $451 in 2025
The $451 reported for 2025 was more than what 82% of Vision Therapy providers received nationally (typical 2025 total: $172).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $20.50 · 2020: $16.69 · 2021: $69.25 · 2022: $242 · 2023: $708 · 2024: $157 · 2025: $451.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,115 · Consulting Fee: $200.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,115.25 |
| Consulting Fee | $200.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coopervision INC. | $588.29 | 2020-2025 | Myday Contact Lens, Misight Contact Lens, Clariti Contact Lens |
| Alcon Vision LLC | $433.14 | 2021-2025 | Total30, Dailies Total1, Hydrus Microstent |
| Bausch & Lomb Americas INC. | $121.37 | 2022-2025 | Miebo, Infuse |
| Abbvie INC. | $113.55 | 2022-2023 | |
| Allergan, INC. | $99.39 | 2022 | |
| Topcon Healthcare, INC. | $88.40 | 2025 | |
| Biotissue Holdings INC. | $70.04 | 2025 | |
| Carl Zeiss Meditec USA, INC. | $67.05 | 2023 | Clarus |
| Johnson & Johnson Vision Care, INC. | $46.83 | 2023 | Acuvue |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $35.88 | 2019-2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Megan Petty listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.